Molina Healthcare supplies managed healthcare providers to low-income households and people by Medicare and Medicaid packages together with state insurance coverage marketplaces. Molina is a multi-state well being care group and headquartered in Lengthy Seashore, California.
The corporate faces escalating operational and monetary pressures that threaten its outlook. Rising regulatory uncertainty tied to ACA subsidies inhibits visibility and coincides with degrading Medicaid enrollment tendencies. Medicaid membership declined 5.2% within the first 9 months of 2025, signaling a heavy burden on enrollment progress.
Excessive prices stay a priority, with working bills swelling constantly over the previous few years and pressuring margins. Profitability challenges have intensified additional as utilization rises, mirrored in a steadily worsening medical care ratio and decreased EPS steering for 2025.
The Zacks Rundown
A Zacks Rank #5 (Sturdy Promote) inventory, Molina Healthcare MOH is a part of the Zacks Medical – HMOs business group, which at the moment ranks within the backside 16% out of roughly 250 Zacks Ranked Industries. As such, we count on this business group as an entire to underperform the market over the following 3 to six months.
Shares within the backside tiers of industries can typically be intriguing quick candidates. Whereas particular person shares have the power to outperform even after they’re a part of a lagging business, the inclusion in a weaker group serves as a headwind for any potential rallies and the journey ahead is that rather more troublesome.
Molina shares have been underperforming the market over the previous 12 months. The inventory hit a 52-week low final month and represents a compelling quick alternative as we close to the top of 2025.
Latest Earnings Misses & Deteriorating Outlook
Molina Healthcare has fallen wanting earnings estimates in three of the previous 4 quarters. Again in October, the corporate reported third-quarter earnings of $1.84 per share, lacking the Zacks Consensus Estimate by a whopping -53.65%.
Molina has posted a trailing four-quarter common earnings miss of -15.8%. Persistently falling wanting earnings estimates is a recipe for underperformance, and MOH is not any exception.
The healthcare supplier has been on the receiving finish of unfavorable earnings estimate revisions as of late. Trying on the fourth quarter, analysts have slashed estimates by -87.28% up to now 60 days. The This autumn Zacks Consensus EPS Estimate is now simply 43 cents per share, reflecting unfavorable progress of -91.5% relative to the year-ago interval.
Picture Supply: Zacks Funding Analysis
Falling earnings estimates are an enormous purple flag and have to be revered. Unfavorable progress year-over-year is the kind of development that bears prefer to see.
Technical Outlook
As illustrated under, MOH inventory is in a sustained downtrend. Discover how the inventory has made a gradual sequence of decrease lows this 12 months, broadly underperforming the key indices. Additionally observe that shares are buying and selling under downward-sloping 50-day (blue line) and 200-day (purple line) transferring averages – one other good signal for the bears.
Picture Supply: StockCharts
MOH inventory has skilled what is called a “demise cross,” whereby the inventory’s 50-day transferring common crosses under its 200-day transferring common. Shares must make an outsized transfer to the upside and present growing earnings estimate revisions to warrant taking any lengthy positions. The inventory has fallen almost 50% this 12 months alone.
Ultimate Ideas
A deteriorating basic and technical backdrop present that this inventory shouldn’t be set to make its solution to new highs anytime quickly. The truth that MOH inventory is included in one of many worst-performing business teams provides one more headwind to an extended checklist of issues.
A historical past of earnings misses and falling future earnings estimates will probably function a ceiling to any potential rallies, nurturing the inventory’s downtrend.
Potential buyers might wish to give this inventory the chilly shoulder, or maybe embody it as a part of a brief or hedge technique. Bulls will wish to keep away from MOH till the state of affairs reveals main indicators of enchancment.
Past Nvidia: AI’s Second Wave Is Right here
The AI revolution has already minted millionaires. However the shares everybody is aware of about aren’t prone to preserve delivering the largest earnings. Little-known AI companies tackling the world’s greatest issues could also be extra profitable within the coming months and years.
See “2nd Wave” AI shares now >>
Molina Healthcare, Inc (MOH) : Free Inventory Evaluation Report
This text initially printed on Zacks Funding Analysis (zacks.com).
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially mirror these of Nasdaq, Inc.
